Expectations trend
FY2028 · fiscal year ending 2028-06-30 · fmp
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.57 → 4.57 EPS · FY ending Jun 30, 2028 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for GOLD yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS at least $2.65 for full year 2026 | A supporting condition in Gold.com, Inc.'s published investment case. The stated target is >= $2.65. | Intact | EPS guidance falls below $2.65 for 2026 | Diluted EPS: $0.37 per share FY2026-Q4; GAAP. Published target: >= $2.65. Target period ends 2026-12-31; this observation covers 2026-Q4. Sep 10, 20260.37 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-06-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a growth and acquisition-led business, with recent results showing stronger revenue and profits. The thesis state is watch: the signal has shifted from mixed to mildly favorable, but recent performance has been below its industry cohort and the evidence is only medium confidence.
The valuation evidence is mixed: GOLD is described as cheap versus peers, yet it also carries a 53% premium versus peers. The priced-in assessment is justified, with low fragility, but the expectations gap is negative, suggesting the market’s assumptions may be demanding relative to the evidence.
Near term, management is delivering on stated priorities: fiscal 2026 revenue and net income rose sharply, and acquisitions helped expand capacity. Still, recent financial performance is neutral, a September earnings miss and a run of misses raise execution risk, and the next guidance update is a key near-term check.
The multi-year thesis depends on management sustaining revenue and profit growth while turning acquired capacity into continued production gains. Near term, a guidance cut would weaken the case; continued strength among financial-sector bellwethers could support sector momentum, while rate cuts are identified as a sector risk.
Over the next one to three years, GOLD has a stronger growth record and improving signal, but the thesis remains on watch because recent relative performance, earnings execution, and mixed valuation evidence leave meaningful questions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Profit and net income rose sharply, with operating income up from $13M to $82M. |
| Broken |
| Net income falls below $10M in any quarter through 2026-Q3 |
Net income: $12.157M FY2026-Q4; GAAP. Published target: >= $59.49M. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 10, 202612,157,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating income to reach at least $81.75M by 2026-Q3 | Profit and net income rose sharply, with operating income up from $13M to $82M. | Broken | Operating income falls below $13M in any quarter through 2026-Q3 | Operating income: $22.241M FY2026-Q4; GAAP. Published target: >= $81.75M. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 10, 202622,241,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth to at least $10.35B by 2026-Q3 | A primary condition in Gold.com, Inc.'s published investment case. The stated target is >= $10.35B. | Intact | Revenue falls below $2.5B in any quarter through 2026-Q3 | Revenue: $5.005B FY2026-Q4; GAAP. Published target: >= $10.35B. The stored target says 2026-Q3; this source reports FY2026-Q4. Fiscal/calendar alignment needs review. Sep 10, 20265,005,014,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.50 → $4.57 · observed estimates
$22.70B → $18.69B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-07-25 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-07-26 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-07-27 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-07-28 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-07-29 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-07-30 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-07-31 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-01 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-02 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-03 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-04 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-05 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-06 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-07 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-08 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-09 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-10 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-12 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-13 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-14 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-15 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-16 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-17 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-18 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-19 | $4.50 | $22,703,600,000 | 2 / 2 |
| 2026-08-20 | $4.50 | $22,703,591,100 | 2 / 2 |
| 2026-08-21 | $4.50 | $22,703,591,100 | 2 / 2 |
| 2026-08-22 | $4.50 | $22,703,591,100 | 2 / 2 |
| 2026-08-23 | $4.50 | $22,703,591,100 | 2 / 2 |
| 2026-08-24 | $4.50 | $22,703,591,100 | 2 / 2 |
| 2026-08-25 | $4.50 | $22,703,591,100 | 2 / 2 |
| 2026-08-26 | $4.50 | $22,703,591,100 | 2 / 2 |
| 2026-08-27 | $4.50 | $22,703,591,100 | 2 / 2 |
| 2026-08-28 | $4.50 | $22,703,591,100 | 2 / 2 |
| 2026-08-29 | $4.48 | $22,703,600,000 | 2 / 2 |
| 2026-08-30 | $4.48 | $22,703,600,000 | 2 / 2 |
| 2026-08-31 | $4.48 | $22,703,600,000 | 2 / 2 |
| 2026-09-01 | $4.48 | $22,703,600,000 | 2 / 2 |
| 2026-09-02 | $4.48 | $22,703,600,000 | 2 / 2 |
| 2026-09-03 | $3.84 | $25,327,400,000 | 2 / 2 |
| 2026-09-04 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-05 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-06 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-07 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-08 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-09 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-10 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-11 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-12 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-13 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-14 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-15 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-16 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-17 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-18 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-19 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-20 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-21 | $4.57 | $18,691,200,000 | 3 / 3 |
| 2026-09-22 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-09-23 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-09-24 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-09-25 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-09-26 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-09-27 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-09-28 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-09-29 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-09-30 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-01 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-02 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-03 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-04 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-05 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-06 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-07 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-08 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-09 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-10 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-11 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-12 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-13 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-14 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-15 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-16 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-17 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-18 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-19 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-20 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-21 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-22 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-23 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-24 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-25 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-26 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-27 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-28 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-29 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-30 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-10-31 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-11-01 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-11-02 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-11-03 | $4.57 | $18,691,202,533 | 3 / 3 |
| 2026-11-04 | $4.57 | $18,691,202,533 | 3 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 5 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.